AU2009334626B2 - Use of an immunoglobulin G (IgG) concentrate depleted of anti-A and anti-B antibodies for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the ABO system - Google Patents

Use of an immunoglobulin G (IgG) concentrate depleted of anti-A and anti-B antibodies for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the ABO system

Info

Publication number
AU2009334626B2
AU2009334626B2 AU2009334626A AU2009334626A AU2009334626B2 AU 2009334626 B2 AU2009334626 B2 AU 2009334626B2 AU 2009334626 A AU2009334626 A AU 2009334626A AU 2009334626 A AU2009334626 A AU 2009334626A AU 2009334626 B2 AU2009334626 B2 AU 2009334626B2
Authority
AU
Australia
Prior art keywords
maternal
immunoglobulin
igg
antibodies
respect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2009334626A
Other versions
AU2009334626A1 (en
Inventor
Mazen Elzaabi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LFB SA
Original Assignee
LFB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0807105A external-priority patent/FR2939667B1/en
Application filed by LFB SA filed Critical LFB SA
Publication of AU2009334626A1 publication Critical patent/AU2009334626A1/en
Application granted granted Critical
Publication of AU2009334626B2 publication Critical patent/AU2009334626B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2009334626A 2008-12-17 2009-12-16 Use of an immunoglobulin G (IgG) concentrate depleted of anti-A and anti-B antibodies for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the ABO system Ceased AU2009334626B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0807105A FR2939667B1 (en) 2008-12-17 2008-12-17 IMMUNOGLOBIN G COMPOSITION AS A MEDICAMENT FOR THE TREATMENT OF NEONATAL ICTERA BY FETOMATERNAL INCOMPATIBILITY IN THE ABO SYSTEM
FR0807105 2008-12-17
PCT/FR2009/052558 WO2010076496A1 (en) 2008-12-17 2009-12-16 Use of an immunoglobulin g (igg) concentrate depleted of anti-a and anti-b antibodies for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the abo system

Publications (2)

Publication Number Publication Date
AU2009334626A1 AU2009334626A1 (en) 2011-08-11
AU2009334626B2 true AU2009334626B2 (en) 2014-12-11

Family

ID=

Similar Documents

Publication Publication Date Title
IL213618A0 (en) Use of an immunoglobulin g (igg) concentrate depleted of anti-a and anti-b antibodies for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the abo system
PL1968634T3 (en) PROCESS FOR PREPARING AN IMMUNOGLOBULIN G (IgG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES
NZ706751A (en) Low affinity blood brain barrier receptor antibodies and uses therefor
WO2012024650A3 (en) Anti-ngf antibodies and their use
IL232219B (en) Human or humanized anti-tar-dna-binding protein 43kda antibodies and uses thereof
WO2010081679A3 (en) Antibodies against human epo receptor
IL223424B (en) Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
WO2013064701A3 (en) Specific antibodies and their isolation with anti-idiotypic antibodies
MX361713B (en) Antigen-binding molecule for promoting loss of antigens.
WO2012064836A9 (en) Methods and compositions for neural disease immunotherapy
MX343659B (en) Fc RECEPTOR BINDING PROTEINS.
WO2013063613A3 (en) Methods and compositions related to intracellular neutralization by igg
DK2623592T3 (en) ANTI-HUMAN CCR7 ANTIBODIES, HYBRIDOM, MEDICAL COMPOSITION AND ANTIBODY IMMOBILIZED CARRIER
EP2492689B8 (en) Detection of antibodies using an improved immune complex (IC) ELISA
ZA201403564B (en) Monoclonal antibodies specific for the m2-1 antigen of respiratory syncytial virus (rsv)
IL210870A0 (en) Method of determination of receptor binding saturation effected by monoclonal antibodies
EP2575882A4 (en) Humanized monoclonal antibodies and methods of use
EP3467498A4 (en) Anti-human hemoglobin monoclonal antibody or antibody kit, insoluble carrier particle to which anti-human hemoglobin monoclonal antibody is immobilized, and measurement reagent and measurement method using same
AU2009334626B2 (en) Use of an immunoglobulin G (IgG) concentrate depleted of anti-A and anti-B antibodies for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the ABO system
EP2133309A4 (en) Method for preparation of an aluminosilicate with ferrierite structure from gels containing tetramethyl ammonium and benzylmethylpyrrolidine, and uses thereof
WO2009104100A3 (en) Antibody combinations, and methods of making and using same
HK1193615A1 (en) Anti-human epo receptor antibodies and methods of use - epo
WO2012110968A3 (en) Treatment of fistulizing crohn's disease
WO2013066986A8 (en) Antibody response phenotyping
SG11201504035PA (en) Humanized monoclonal antibodies against activated protein c and uses thereof